Search results
Bain Capital-backed 360 ONE plans a bet on EM-focused fund by Ruchir Sharma
CNBC Awaaz· 21 hours agoOne of India’s largest wealth managers is moving to capitalize on the country’s free market haven,...
Krafton India CEO sees bright future for gaming in the region, backs AI innovation
Business Today· 54 minutes agoIn an exclusive interview with Tech Today, Krafton India CEO Sean Hyunil Sohn shared his insights on...
What we learned as Jones, Timme power Kings' emphatic win over Jazz
NBC Sports BayArea· 20 minutes agoSacramento, as a whole, looked a lot more comfortable and confident after getting rocked by the...
aespa's Giselle opens up about recent group activities and team strength | K-pop Movie News - Times...
The Times of India· 9 hours agoHaving wrapped up aespa’s first full-length album promotions, Giselle highlighted the team spirit...
The Boys Season 4 Episode 8: What To Expect Next
Pinkvilla· 17 hours agoThe Boys Season 4 is just one episode away from its conclusion. The last episode presented some major developments in the story as Butcher ...
Elon Musk to give $45 million every month to pro-Trump political group
Business Standard India· 2 hours agoThe billionaire entrepreneur endorsed Trump in a post on X after the former president was wounded...
Trump's economic plans include proposed tariffs, tax cuts, no taxes on tips
Business Standard India· 1 hour agoSpeakers argued that Trump would fix inflation and bring back prosperity simply by returning to the...
Best Fan Theories About Lucky Spencer’s General Hospital Return
SOAPHUB· 8 hours agoWhere We Last Saw Lucky While Lucky...Jackson recently had to say about his TV mom) possibly being...
Edavanakad residents to set protest path again as their ultimatum goes unheeded
The Hindu· 8 hours agoThe collective had intensified...and a hartal in quick succession last month. The stir was called off temporarily after the district ...
Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data
BioPharma Dive· 17 hours agoUpdated results show the biotech's RAS inhibitor shrank pancreatic tumors in 20% to 25% of study...